Last reviewed · How we verify
NCT03042884
Wearable Exercise Trackers in Cancer Rehabilitation
NA trial testing Questionnaires in Benign Neoplasms in 111 participants. Completed in 14 December 2020.
14 December 2020
Quick facts
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 111 |
| Start date | 13 February 2017 |
| Primary completion | 14 December 2020 |
| Estimated completion | 14 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Questionnaires
- Wearable Exercise Tracker Watch
Conditions studied
- Benign Neoplasms — all drugs for Benign Neoplasms →
- In Situ Neoplasms — all drugs for In Situ Neoplasms →
- Malignant Neoplasms of Independent (Primary) Multiple Sites — all drugs for Malignant Neoplasms of Independent (Primary) Multiple Sites →
Sponsor
M.D. Anderson Cancer Center — full company profile →
Who can join
18 and older, any sex, with Benign Neoplasms or In Situ Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this research study is to learn how useful a wearable exercise tracker watch is to monitor your physical activity. This is an investigational study. Up to 100 participants will be enrolled in this study. All will take part at MD Anderson.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03042884
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaires
Trials testing the same drug.
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07499518 — Fertility and Polycystic Ovary Syndrome · not yet recruiting
- NCT07487844 — Pulsed Electric Field Ablation for Metastatic Breast Cancer · NA · not yet recruiting
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT06836414 — Lung Cancer Screening CT for Firefighters · NA · withdrawn
Other recruiting trials for Benign Neoplasms
Currently open trials in the same condition.
- NCT02911064 — Expectations Regarding Mobility and Self-Care · active not recruiting
Other M.D. Anderson Cancer Center trials
Trials by the same sponsor.
- NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
- NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
- NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
- NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
- NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03042884 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
- Last refreshed: 17 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03042884.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing